Clinical Study on the Effects of Shatapushpa Taila and Lashuna Taila Nasya in Anovulation

Phase 2

Not yet recruiting

Conditions: Female infertility associated withanovulation. Ayurveda Condition: VANDHYA,

Registration Number: CTRI/2025/04/083832

Lead Sponsor: SHREE SWAMINARAYAN AYURVEDIC MEDICAL COLLEGE

Brief Summary: **Title:****“A COMPARATIVE CLINICAL TRIAL TO EVALUATE EFFICACY OF SHATAPUSHPA TAILA AND LASHUNA TAILA NASYA ON ABEEJOTSARGA W.S.R TO AN-OVULATION” – AN OPEN LABEL RANDOMISED CONTROLLED TRIAL.**

Infertility, particularly an-ovulation, is a significant concern affecting approximately 30% of infertility cases. Ayurveda offers a holistic approach to managing an-ovulation through Nasya therapy.

This randomized controlled trial aims to evaluate the efficacy of **Shatapushpa Taila Nasya** and **Lashuna Taila Nasya** in promoting ovulation.

Shatapushpa (Anethum sowa) is known for its **Beejotsarga** and **Artavajanana** properties, aiding in follicular development and hormonal balance. Lashuna (Allium sativum) is described as a potent fertility enhancer that regulates hormonal imbalances and supports oogenesis. Since **Nasya (nasal administration)** directly influences the brain and hormonal pathways, it is expected to play a vital role in restoring ovulatory functions.

This open-label randomized controlled trial will assess the impact of these Ayurvedic interventions on ovulation, providing a cost-effective, safe, and natural alternative for infertility management.

Assessment will be done on the basis of subjective and objective criteria and investigations.

Detailed Description: Not available

Recruitment & Eligibility

Status: Not Yet Recruiting

Sex: Female

Target Recruitment: 40

Inclusion Criteria

Primary and secondary infertility Complain of an-ovulatory factors The patients of child bearing age.

Exclusion Criteria

Reproductive tract tuberculosis, carcinoma, Congenital deformities Chronic illness, Cardiac diseases, Thyroid disorders, Tubal blockage, uterine factors, •Patient not suitable for nasya.

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Induction of Ovulation: Improvement in follicular development and ovulation as assessed by ultrasonography.	7 days
Hormonal Balance: Regulation of LH, FSH, and estrogen-progesterone levels.	7 days
Menstrual Regularity: Improvement in cycle length, flow, and reduction of oligomenorrhea/amenorrhea.	7 days

Secondary Outcome Measures

Name	Time	Method
Improvement in general well-being	Nasya-specific benefits

Trial Locations

Locations (1): Premswarup swami ayurvedic multispeciality hospital
🇮🇳
Gandhinagar, GUJARAT, India
Premswarup swami ayurvedic multispeciality hospital
🇮🇳Gandhinagar, GUJARAT, India
Dr Hridaynath lad
Principal investigator
hridaynath.lad@gmail.com